Idt Biologika

Idt Biologika company information, Employees & Contact Information

Explore related pages

Related company profiles:

IDT Biologika is your full-service CDMO for viral vaccines, cell & gene therapeutics and other biologics protecting humans worldwide! We are committed to your development and manufacturing needs from the early stages of process development to clinical trial materials and commercial manufacturing: • Process Development • Clinical & Commercial Scale Drug Substance (e.g. Viral Vaccines, Viral Vectors for Cell and Gene Therapeutics) • Aseptic Liquid Filling & Lyophilization (Biologics) • Labeling, Packaging & Storage • Quality Control and Analytical Services With the expertise and capacity to handle large-scale campaign production of human vaccines and biopharmaceuticals, IDT Biologika brings development, testing and regulatory excellence along with state-of-the-art manufacturing lines required to advance projects with the highest level of quality, efficiency and consistency of supply: • FDA, EMA, ANVISA standards European and North American Footprint IDT Biologika is headquartered in Germany (Dessau-Rosslau and Magdeburg in Saxony-Anhalt). Here we operate one of Europe’s premier integrated biopharmaceutical facilities for end-to-end services: • Process Development • Clinical Phases I-III • Commercial Scale Drug Substance (e.g. Viral Vaccines, Viral Vectors for Cell and Gene Therapeutics) • Commercial Manufacturing • Aseptic Liquid Filling & Lyophilization (Biologics) • Labeling, Packaging & Storage • Quality Control and Analytical Services Our North American facility is in Rockville, Maryland. The site has a long history of contract manufacturing and state-of-the-art technologies used to develop and manufacture clinical trial materials for phases I–II: • Process Development • Clinical-Scale Drug Substance (Viral Vaccines, Viral Vectors for Cell & Gene Therapeutics) • Aseptic Liquid Filling & Lyophilization • Packaging & Storage • Analytical Service

Company Details

Employees
490
Founded
-
Address
Am Pharmapark, Dessau-Rosslau,sachsen-Anhalt 06861,germany
Phone
+49 (0)34901 8850
Email
in****@****ika.com
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Dessau-Rosslau, Sachsen-Anhalt
Looking for a particular Idt Biologika employee's phone or email?

Idt Biologika Questions

News

IDT Biologika Accelerates Global Growth Through Strategic CDMO Partnership - PR Newswire

IDT Biologika Accelerates Global Growth Through Strategic CDMO Partnership PR Newswire

IDT Biologika Enters CMDO Partnership to Accelerate Global Growth - Contract Pharma

IDT Biologika Enters CMDO Partnership to Accelerate Global Growth Contract Pharma

'Strong synergies': IDT Biologika expands SK bioscience's global reach into new projects - Korea JoongAng Daily

'Strong synergies': IDT Biologika expands SK bioscience's global reach into new projects Korea JoongAng Daily

IDT Biologika Appoints Chief Commercial Officer - Contract Pharma

IDT Biologika Appoints Chief Commercial Officer Contract Pharma

SK Bioscience begins 'globalization' push, paying $244M for majority stake in contract manufacturer IDT Biologika - Fierce Pharma

SK Bioscience begins 'globalization' push, paying $244M for majority stake in contract manufacturer IDT Biologika Fierce Pharma

SK takes controlling stake of CDMO IDT Biologika - BioProcess International

SK takes controlling stake of CDMO IDT Biologika BioProcess International

IDT Biologika Acquired for $244M by SK Bioscience to Fuel Global Expansion - BioBuzz

IDT Biologika Acquired for $244M by SK Bioscience to Fuel Global Expansion BioBuzz

News from DCAT Week 2022: IDT Biologika Announcing $100-M-Plus Expansion Plan - DCAT Value Chain Insights

News from DCAT Week 2022: IDT Biologika Announcing $100-M-Plus Expansion Plan DCAT Value Chain Insights

IDT Biologika establishes Animal Health Americas business unit - Feedstuffs

IDT Biologika establishes Animal Health Americas business unit Feedstuffs

From the experts: How to successfully implement Annex 1 regulations - Pharmaceutical Technology

From the experts: How to successfully implement Annex 1 regulations Pharmaceutical Technology

SK Bioscience to buy German vaccine maker IDT Biologika for $244 mn - The Korea Economic Daily Global Edition

SK Bioscience to buy German vaccine maker IDT Biologika for $244 mn The Korea Economic Daily Global Edition

SK Bioscience Acquires Majority Stake in IDT Biologika - CHEManager

SK Bioscience Acquires Majority Stake in IDT Biologika CHEManager

SK Bioscience to acquire Klocke’s CDMO in cross-holding M&A - BioWorld MedTech

SK Bioscience to acquire Klocke’s CDMO in cross-holding M&A BioWorld MedTech

Overcoming Manufacturing Complexities in Biopharma: Smarter Paths to Clinical and Commercial Success - Fierce Biotech

Overcoming Manufacturing Complexities in Biopharma: Smarter Paths to Clinical and Commercial Success Fierce Biotech

IDT Biologika - Contract Pharma

IDT Biologika Contract Pharma

SK bioscience sees revenue surge in Q1 thanks to German subsidiary - koreabiomed.com

SK bioscience sees revenue surge in Q1 thanks to German subsidiary koreabiomed.com

South Korea's SK bioscience Completes Acquisition of Germany's CDMO IDT Biologika - PR Newswire

South Korea's SK bioscience Completes Acquisition of Germany's CDMO IDT Biologika PR Newswire

IDT Biologika on the importance of oncolytic viruses in CGT development - BioProcess International

IDT Biologika on the importance of oncolytic viruses in CGT development BioProcess International

IDT Biologika opens vaccine manufacturing facility in Germany - Fierce Pharma

IDT Biologika opens vaccine manufacturing facility in Germany Fierce Pharma

SK Bioscience Reports 73% Revenue Growth in Q4 2024, Driven by IDT Biologika Acquisition and Vaccine Expansionv - BioSpectrum Asia

SK Bioscience Reports 73% Revenue Growth in Q4 2024, Driven by IDT Biologika Acquisition and Vaccine Expansionv BioSpectrum Asia

SK bioscience swings to loss in 2024 on R&D spend but bets on IDT Biologika for turnaround - koreabiomed.com

SK bioscience swings to loss in 2024 on R&D spend but bets on IDT Biologika for turnaround koreabiomed.com

SK Bioscience completes acquisition of German biotech IDT Biologika - The Korea Times

SK Bioscience completes acquisition of German biotech IDT Biologika The Korea Times

SK bioscience completes acquisition of German biotech firm IDT Biologika - Yonhap News Agency

SK bioscience completes acquisition of German biotech firm IDT Biologika Yonhap News Agency

AstraZeneca signs LOI with IDT Biologika to boost Europe’s Covid-19 vaccine-making capability - Pharmaceutical Business review -

AstraZeneca signs LOI with IDT Biologika to boost Europe’s Covid-19 vaccine-making capability Pharmaceutical Business review -

Through their PROVEO™ Partnership, CMC Biologics and IDT Biologika Announce the Addition of Cerbios-Pharma and Oncotec Pharma to their Strategic Collaboration for Manufacture of Antibody Drug Conjugates - PR Newswire

Through their PROVEO™ Partnership, CMC Biologics and IDT Biologika Announce the Addition of Cerbios-Pharma and Oncotec Pharma to their Strategic Collaboration for Manufacture of Antibody Drug Conjugates PR Newswire

Development of a MERS vaccination - Deutsches Zentrum für Infektionsforschung

Development of a MERS vaccination Deutsches Zentrum für Infektionsforschung

IDT Biologika Live Human Viral Vaccine Production Facility - Pharmaceutical Technology

IDT Biologika Live Human Viral Vaccine Production Facility Pharmaceutical Technology

Top Idt Biologika Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant